Neurogenin 3–Directed Cre Deletion of Tsc1 Gene Causes Pancreatic Acinar Carcinoma

[1]  J. Herman,et al.  Whole‐exome sequencing of pancreatic neoplasms with acinar differentiation , 2014, The Journal of pathology.

[2]  S. Takao,et al.  mTOR plays critical roles in pancreatic cancer stem cells through specific and stemness-related functions , 2013, Scientific Reports.

[3]  A. Maitra,et al.  Phosphorylation of ribosomal protein S6 attenuates DNA damage and tumor suppression during development of pancreatic cancer. , 2013, Cancer research.

[4]  He N. Xu,et al.  Imaging heterogeneity in the mitochondrial redox state of premalignant pancreas in the pancreas-specific PTEN-null transgenic mouse model , 2013, Biomarker Research.

[5]  T. Han,et al.  Hepatic transforming growth factor beta gives rise to tumor‐initiating cells and promotes liver cancer development , 2012, Hepatology.

[6]  L. Bergmann,et al.  The dual PI3K/mTOR inhibitor NVP-BGT226 induces cell cycle arrest and regulates Survivin gene expression in human pancreatic cancer cell lines , 2012, Tumor Biology.

[7]  M. Barbacid,et al.  What we have learned about pancreatic cancer from mouse models. , 2012, Gastroenterology.

[8]  R. Bronson,et al.  Chronic Activation of mTOR Complex 1 Is Sufficient to Cause Hepatocellular Carcinoma in Mice , 2012, Science Signaling.

[9]  Anthony Beucher,et al.  Competence of failed endocrine progenitors to give rise to acinar but not ductal cells is restricted to early pancreas development. , 2012, Developmental biology.

[10]  M. Lowery,et al.  Acinar cell carcinoma of the pancreas: new genetic and treatment insights into a rare malignancy. , 2011, The oncologist.

[11]  M. Jansen,et al.  Analysis of LKB1 mutations and other molecular alterations in pancreatic acinar cell carcinoma , 2011, Modern Pathology.

[12]  B. Wiedenmann,et al.  From Targets to Treatments: A Review of Molecular Targets in Pancreatic Neuroendocrine Tumors , 2011, Neuroendocrinology.

[13]  Gerald C. Chu,et al.  PTEN is a major tumor suppressor in pancreatic ductal adenocarcinoma and regulates an NF-κB-cytokine network. , 2011, Cancer discovery.

[14]  Michael A. Choti,et al.  DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors , 2011, Science.

[15]  D. Richel,et al.  mTOR inhibitor treatment of pancreatic cancer in a patient With Peutz-Jeghers syndrome. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  C. Wright,et al.  Neurog3 gene dosage regulates allocation of endocrine and exocrine cell fates in the developing mouse pancreas. , 2010, Developmental biology.

[17]  M. Mulholland,et al.  Gastric mammalian target of rapamycin signaling regulates ghrelin production and food intake. , 2009, Endocrinology.

[18]  G. Parmigiani,et al.  Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses , 2008, Science.

[19]  Xian Wang,et al.  Homocysteine Upregulates Resistin Production From Adipocytes In Vivo and In Vitro , 2008, Diabetes.

[20]  T. Okada,et al.  Rapamycin enhances the anti-tumor effect of gemcitabine in pancreatic cancer cells. , 2007, Hepato-gastroenterology.

[21]  T. Veenstra,et al.  Identification of a Highly Effective Rapamycin Schedule that Markedly Reduces the Size, Multiplicity, and Phenotypic Progression of Tobacco Carcinogen–Induced Murine Lung Tumors , 2006, Clinical Cancer Research.

[22]  E. Kakiashvili,et al.  The mTOR inhibitor rapamycin down-regulates the expression of the ubiquitin ligase subunit Skp2 in breast cancer cells , 2006, Breast Cancer Research.

[23]  D. Ito,et al.  In vivo antitumor effect of the mTOR inhibitor CCI‐779 and gemcitabine in xenograft models of human pancreatic cancer , 2006, International journal of cancer.

[24]  D. Ito,et al.  Expression and prognostic value of tuberous sclerosis complex 2 gene product tuberin in human pancreatic cancer. , 2005, Surgery.

[25]  J. Ferlay,et al.  Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.

[26]  D. Mukhopadhyay,et al.  Effect of Rapamycin Alone and in Combination with Antiangiogenesis Therapy in an Orthotopic Model of Human Pancreatic Cancer , 2004, Clinical Cancer Research.

[27]  N. Sonenberg,et al.  Upstream and downstream of mTOR. , 2004, Genes & development.

[28]  Susan E. Schonhoff,et al.  Neurogenin 3-expressing progenitor cells in the gastrointestinal tract differentiate into both endocrine and non-endocrine cell types. , 2004, Developmental biology.

[29]  R. Yeung,et al.  The Tuberous Sclerosis Complex Genes in Tumor Development , 2004, Cancer investigation.

[30]  D. Longnecker,et al.  Preinvasive pancreatic neoplasia of ductal phenotype induced by acinar cell targeting of mutant Kras in transgenic mice. , 2003, Cancer research.

[31]  D. Melton,et al.  Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors. , 2002, Development.

[32]  J. Cameron,et al.  Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway. , 2002, The American journal of pathology.

[33]  F. Greten,et al.  TGFα Transgenic Mice , 2001, Pancreatology.

[34]  F. Guillemot,et al.  neurogenin3 is required for the development of the four endocrine cell lineages of the pancreas. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  O. Madsen,et al.  Independent development of pancreatic alpha- and beta-cells from neurogenin3-expressing precursors: a role for the notch pathway in repression of premature differentiation. , 2000, Diabetes.

[36]  David J. Anderson,et al.  Notch signalling controls pancreatic cell differentiation , 1999, Nature.

[37]  D. Longnecker,et al.  Pancreatic carcinomas of acinar and mixed acinar/ductal phenotypes in Ela-1-myc transgenic mice do not contain c-K-ras mutations. , 1994, The American journal of pathology.

[38]  Stephen A. Sastra,et al.  Quantification of murine pancreatic tumors by high-resolution ultrasound. , 2013, Methods in molecular biology.

[39]  S. Onda,et al.  [Pancreatic carcinoma]. , 2012, Nihon rinsho. Japanese journal of clinical medicine.

[40]  A. Jemal,et al.  Cancer Statistics, 2004 , 2004, CA: a cancer journal for clinicians.

[41]  R. Schmid,et al.  TGF alpha transgenic mice. A model of pancreatic cancer development. , 2001, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.].

[42]  A. Jemal,et al.  Global cancer statistics , 2011, CA: a cancer journal for clinicians.